💨 Abstract

Editas Medicine Inc. reported a $76.1 million loss in the first quarter of 2025, equivalent to 92 cents per share. Adjusted for restructuring costs, the loss was 43 cents per share, beating Wall Street's expectations of a 51 cents per share loss. The company's revenue of $4.7 million also surpassed analyst forecasts of $960,000.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖